{"transactions":[{"id":2391527,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":130339,"kind":"person","name":"Garcia-Parada Carlos","position":1,"cik":"0001839342","reported_name":"Garcia-Parada Carlos","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-17T02:32:16.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":17322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":17322,"derivative":{"underlying":"Common Stock","underlying_shares":17322},"source":{"system":"sec-edgar","filing":"0001140361-22-005831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122005831/form4.xml","form_type":"4"}},{"id":2391526,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":130339,"kind":"person","name":"Garcia-Parada Carlos","position":1,"cik":"0001839342","reported_name":"Garcia-Parada Carlos","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T02:32:16.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":54006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 54,006 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":54006,"derivative":{"exercise_price":20,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":54006},"source":{"system":"sec-edgar","filing":"0001140361-22-005831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122005831/form4.xml","form_type":"4"}},{"id":2569136,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":130339,"kind":"person","name":"Garcia-Parada Carlos","position":1,"cik":"0001839342","reported_name":"Garcia-Parada Carlos","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-15T20:07:33.000Z","date":"2021-09-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on September 13, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":40000,"derivative":{"exercise_price":35.6,"expiration_date":"2031-09-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-21-031349","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121031349/form4.xml","form_type":"4"}},{"id":2915159,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":130339,"kind":"person","name":"Garcia-Parada Carlos","position":1,"cik":"0001839342","reported_name":"Garcia-Parada Carlos","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T01:21:39.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 125,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on January 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":125000,"derivative":{"exercise_price":56.49,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001140361-21-000393","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121000393/form4.xml","form_type":"4"}}]}